SynBioBeta Speaker
Huafeng Xu
Atommap
Founder and CEO
Huafeng Xu, Ph. D., is the co-founder and CEO of Atommap, a New York-based biotech company transforming drug discovery through advanced computational methods. Atommap’s proprietary platform harnesses biomolecular dynamics to deliver therapeutic molecules that reprogram protein function. Since its founding in 2023, Atommap has partnered with 11 companies in their discovery projects and has on its own developed first-in-class molecules addressing a challenging oncological target. Huafeng previously served as Chief Technology Officer of Silicon Therapeutics, which Roivant acquired in 2021, then as CTO of Roivant Discovery before launching Atommap with his co-founders. Over his 25-year career as a chemist and computer scientist, he has developed the methods and software for molecular dynamics simulations and free energy calculations that are now widely used in the pharmaceutical industry, and he has pioneered the industrial application of computation-driven drug design. His publications have garnered over 10,000 citations. He earned his Bachelor of Science from Peking University and his M.S. and Ph. D. from Columbia University, and was a visiting postdoctoral scholar in UC San Francisco. In his spare time, Huafeng enjoys wine and solving math problems, sometimes simultaneously.
All Categories
